ReviewExpert opinion on therapeutic targets2019

Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Joshua B Bilsborrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.